*To be consumed as directed by physician.
Therapies:
Biotech Product
Composition:
Rituximab (500 mg)
Maball 500 mg Injection contains Rituximab, a targeted monoclonal antibody that works by attaching to the CD20 protein found on B-lymphocytes, a type of immune cell involved in certain blood cancers and autoimmune diseases. It is commonly prescribed for conditions such as non-Hodgkin lymphoma, chronic lymphocytic leukaemia (CLL), rheumatoid arthritis that does not respond well to standard treatments, and vasculitis disorders like granulomatosis with polyangiitis. It helps the body's immune system identify and destroy these abnormal cells, supports better disease control and slows progression.
*To be consumed as directed by physician.